Hide metadata

dc.date.accessioned2018-08-20T11:39:07Z
dc.date.available2018-08-20T11:39:07Z
dc.date.created2017-10-08T16:41:13Z
dc.date.issued2017
dc.identifier.citationRodriguez-Calvo, Teresa Zapardiel-Gonzalo, Jose Amirian, Natalie Castillo, Ericka Lajevardi, Yasaman Krogvold, Lars Dahl-Jørgensen, Knut Von Herrath, Matthias G. . Increase in pancreatic proinsulin and preservation of β-cell mass in autoantibody-positive donors prior to type 1 diabetes onset. Diabetes. 2017, 66(5), 1334-1345
dc.identifier.urihttp://hdl.handle.net/10852/63236
dc.description.abstractType 1 diabetes is characterized by the loss of insulin production caused by β-cell dysfunction and/or destruction. The hypothesis that β-cell loss occurs early during the prediabetic phase has recently been challenged. Here we show, for the first time in situ, that in pancreas sections from autoantibody-positive (Ab+) donors, insulin area and β-cell mass are maintained before disease onset and that production of proinsulin increases. This suggests that β-cell destruction occurs more precipitously than previously assumed. Indeed, the pancreatic proinsulin-to-insulin area ratio was also increased in these donors with prediabetes. Using high-resolution confocal microscopy, we found a high accumulation of vesicles containing proinsulin in β-cells from Ab+ donors, suggesting a defect in proinsulin conversion or an accumulation of immature vesicles caused by an increase in insulin demand and/or a dysfunction in vesicular trafficking. In addition, islets from Ab+ donors were larger and contained a higher number of β-cells per islet. Our data indicate that β-cell mass (and function) is maintained until shortly before diagnosis and declines rapidly at the time of clinical onset of disease. This suggests that secondary prevention before onset, when β-cell mass is still intact, could be a successful therapeutic strategy. © 2017 American Diabetes Associationen_US
dc.languageEN
dc.publisherThe American Diabetes Association
dc.titleIncrease in pancreatic proinsulin and preservation of β-cell mass in autoantibody-positive donors prior to type 1 diabetes onseten_US
dc.typeJournal articleen_US
dc.creator.authorRodriguez-Calvo, Teresa
dc.creator.authorZapardiel-Gonzalo, Jose
dc.creator.authorAmirian, Natalie
dc.creator.authorCastillo, Ericka
dc.creator.authorLajevardi, Yasaman
dc.creator.authorKrogvold, Lars
dc.creator.authorDahl-Jørgensen, Knut
dc.creator.authorVon Herrath, Matthias G.
cristin.unitcode185,16,17,56
cristin.unitnameAvdeling for pedodonti og atferdsfag
cristin.ispublishedtrue
cristin.fulltextpostprint
cristin.qualitycode2
dc.identifier.cristin1503137
dc.identifier.bibliographiccitationinfo:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Diabetes&rft.volume=66&rft.spage=1334&rft.date=2017
dc.identifier.jtitleDiabetes
dc.identifier.volume66
dc.identifier.issue5
dc.identifier.startpage1334
dc.identifier.endpage1345
dc.identifier.doihttp://dx.doi.org/10.2337/db16-1343
dc.identifier.urnURN:NBN:no-65793
dc.type.documentTidsskriftartikkelen_US
dc.type.peerreviewedPeer reviewed
dc.source.issn0012-1797
dc.identifier.fulltextFulltext https://www.duo.uio.no/bitstream/handle/10852/63236/2/Manuscript_Rodriguez-Calvo_R2%2BPROOF.pdf
dc.type.versionAcceptedVersion
dc.relation.projectANDRE/National Institutes of Health Grant R01 AI092453-03


Files in this item

Appears in the following Collection

Hide metadata